Some visit links earn us a commission.
Quick verdict
Medvi is the better pick for most patients on overall scoring. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
That said, Shed wins on specific dimensions. Shed offers compounded semaglutide starting at $149/mo on the monthly plan (care and shipping included, no separate membership), escalating by dose. Six and twelve-month plans reduce the per-month cost further. Branded Wegovy, Zepbound and Foundayo are also available.
Side-by-side
| Medvi | Shed | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $149/mo (incl. medication) |
| Monthly cost gap | Medvi is $70/mo cheaper than Shed | |
| Lock-in | Month-to-month | Prepaid plan |
| Time to prescription | 2 days | 3 days |
| Consultation type | Asynchronous | Online |
| Affiliate network | Direct | - |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Medvi | Shed | |
|---|---|---|
| Pricing transparency | 8/10 | 6/10 |
| Cancellation terms | 8/10 | 6/10 |
| Onboarding experience | 7/10 | 7/10 |
| Medication options | 7/10 | 7/10 |
| Member reviews | 9/10 | 8/10 |
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on pricing transparency, cancellation terms, member reviews and runs $70/mo cheaper than Shed at the entry tier ($179 vs $249). Over a year that's $840 you keep. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
When to choose Shed
Best for all-in compounded with care included
Cash-pay patients who want an all-in compounded price with care included at a low entry price, and who are willing to commit to a longer plan for a lower monthly cost.
Shed wins on tied dimensions on the dimensional scoring. The caveat: Patients who want the cheapest month-to-month compounded price at high doses, or who specifically want branded GLP-1s billed through insurance. Note also: Compounded GLP-1s are not FDA-approved and are made by a licensed pharmacy under a prescription.
If cost is your main filter
Medvi is the cheaper monthly: $179 all-in vs $249 for Shed. That's $70 a month or $840a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $210 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Medvi (month-to-month) and Shed (prepaid plan) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Medvi's easier cancellation is the safer trial.
FAQ
Is Medvi cheaper than Shed?
Can I switch from Medvi to Shed mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
